Charles Schwab
SFE

Charles Schwab’s Safeguard Scientifics, Inc. SFE Stock Holding History

Charles Schwab’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,218
Closed -$9.59K – 3563
2023
Q4 		$9.59K Hold
12,218
– – ﹤0.01% 3526
2023
Q3 		$12.2K Hold
12,218
– – ﹤0.01% 3552
2023
Q2 		$20.2K Hold
12,218
– – ﹤0.01% 3559
2023
Q1 		$21K Hold
12,218
– – ﹤0.01% 3506
2022
Q4 		$37.9K Hold
12,218
– – ﹤0.01% 3414
2022
Q3 		$46K Buy
+12,218
New +$49.1K ﹤0.01% 3349
2021
Q3 		– Sell
-98,481
Closed -$765K – 3555
2021
Q2 		$765K Sell
98,481
-41,187
-29% -$281K ﹤0.01% 3021
2021
Q1 		$953K Buy
139,668
+8,814
+7% +$64K ﹤0.01% 2878
2020
Q4 		$835K Buy
130,854
+2,132
+2% +$13.3K ﹤0.01% 2825
2020
Q3 		$706K Sell
128,722
-5,160
-4% -$30.8K ﹤0.01% 2777
2020
Q2 		$938K Buy
133,882
+11,273
+9% +$71.3K ﹤0.01% 2644
2020
Q1 		$681K Buy
122,609
+6,502
+6% +$58.1K ﹤0.01% 2599
2019
Q4 		$1.27M Sell
116,107
-570
-0.5% -$6.51K ﹤0.01% 2528
2019
Q3 		$1.32M Buy
116,677
+13
+0% +$155 ﹤0.01% 2500
2019
Q2 		$1.41M Buy
116,664
+3,520
+3% +$41.2K ﹤0.01% 2476
2019
Q1 		$1.23M Buy
113,144
+4,339
+4% +$44K ﹤0.01% 2494
2018
Q4 		$938K Buy
108,805
+6,577
+6% +$57.4K ﹤0.01% 2555
2018
Q3 		$956K Sell
102,228
-7,750
-7% -$84.2K ﹤0.01% 2643
2018
Q2 		$1.41M Buy
109,978
+12,834
+13% +$166K ﹤0.01% 2479
2018
Q1 		$1.19M Buy
97,144
+23,342
+32% +$284K ﹤0.01% 2473
2017
Q4 		$827K Buy
73,802
+2,964
+4% +$38K ﹤0.01% 2573
2017
Q3 		$946K Sell
70,838
-16,489
-19% -$203K ﹤0.01% 2518
2017
Q2 		$1.04M Buy
87,327
+570
+0.7% +$6.71K ﹤0.01% 2442
2017
Q1 		$1.1M Buy
86,757
+5,130
+6% +$64.6K ﹤0.01% 2396
2016
Q4 		$1.1M Buy
81,627
+4,620
+6% +$57K ﹤0.01% 2398
2016
Q3 		$999K Buy
77,007
+3,954
+5% +$52.4K ﹤0.01% 2412
2016
Q2 		$913K Buy
73,053
+10,400
+17% +$139K ﹤0.01% 2379
2016
Q1 		$831K Buy
62,653
+10,687
+21% +$134K ﹤0.01% 2400
2015
Q4 		$755K Sell
51,966
-8,276
-14% -$134K ﹤0.01% 2486
2015
Q3 		$937K Buy
60,242
+7,130
+13% +$128K ﹤0.01% 2407
2015
Q2 		$1.03M Buy
53,112
+2,050
+4% +$37.6K ﹤0.01% 2398
2015
Q1 		$924K Buy
51,062
+11,000
+27% +$204K ﹤0.01% 2398
2014
Q4 		$795K Sell
40,062
-13,775
-26% -$265K ﹤0.01% 2448
2014
Q3 		$991K Buy
53,837
+1,219
+2% +$24.1K ﹤0.01% 2304
2014
Q2 		$1.09M Sell
52,618
-384
-0.7% -$7.72K ﹤0.01% 2271
2014
Q1 		$1.18M Buy
53,002
+1,440
+3% +$28.6K ﹤0.01% 2208
2013
Q4 		$1.04M Buy
51,562
+8,128
+19% +$144K ﹤0.01% 2251
2013
Q3 		$662K Buy
43,434
+2,328
+6% +$35.8K ﹤0.01% 2424
2013
Q2 		$664K Buy
+41,106
New +$653K ﹤0.01% 2377

Other funds holding SFE

CP
Clayton Partners Berkeley, California $138M AUM 38.58% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
FWM
FSA Wealth Management Needham, Massachusetts $273M AUM 16.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Charles Schwab's SFE Position: Q1 2024 in Review

Charles Schwab sold out of Safeguard Scientifics, Inc. (SFE) in Q1 2024, closing a stake of 12,218 shares — an estimated $9.59K sold.

Charles Schwab first reported a position in SFE in Q2 2013 and held it in 39 quarters. The position peaked at $1.41M in Q2 2019. 4 funds tracked by Wall St. Rank hold SFE as of Q1 2024.

  • Charles Schwab reported no remaining Safeguard Scientifics, Inc. position as of Q1 2024 after selling out during the quarter.
  • Charles Schwab sold 12,218 Safeguard Scientifics, Inc. shares in Q1 2024, an estimated $9.59K.
  • Charles Schwab first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 39 quarters.
  • Charles Schwab's Safeguard Scientifics, Inc. position peaked at $1.41M in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q1 2024.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.